Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
Sponsor
The University of Texas Health Science Center at San Antonio (Other)
Overall Status
Available
CT.gov ID
NCT03493165
Collaborator
(none)
Study Details
Study Description
Brief Summary
Single patient treatment with everolimus.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
Study Design
Study Type:
Expanded Access
Official Title:
Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Female
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- The University of Texas Health Science Center at San Antonio
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:
NCT03493165
Other Study ID Numbers:
- CTMS# 18-0020
First Posted:
Apr 10, 2018
Last Update Posted:
Jul 2, 2021
Last Verified:
Jun 1, 2021